- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00714896
Interventions for Smoking Among Persons in Recovery (INSPIRE)
A Stepped-Care Intervention for Current and Former Smokers in Outpatient Chemical Dependency Treatment
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The objective of the study is to document and systematically investigate the use of smoking cessation strategies targeting substance abuse outpatient smokers at various level of readiness to quit smoking. Little is known regarding the best practices in treating tobacco use among clients in drug abuse treatment and very few drug abuse treatment programs currently offer smoking cessation services. The purpose of this developmental study is to develop and pre-test a stepped-care smoking cessation intervention in an outpatient drug abuse treatment program at a managed care setting that targets both current and former smokers. The stepped-care intervention consists of various components that aim at matching the treatment needs of smokers across the whole spectrum of smoking status and readiness to quit smoking. The following specific aims will be pursued:
- Develop a stepped-care smoking cessation intervention targeting both current and former smokers who are admitted to an outpatient drug abuse treatment program. Special attention will be paid to former smokers, as intervention techniques for them are not well developed. Also, intervention content will be modified from that used in smoking interventions with the general population to content that is targeted at smokers who are in drug abuse treatment
- Pre-test the efficacy of the stepped-care smoking cessation intervention.
- Examine the feasibility of implementing the stepped-care smoking cessation intervention.
- Examine the impact of the smoking intervention on drug and alcohol use outcomes at 6-month post initiation of smoking cessation treatment.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
California
-
Walnut Creek, California, Stati Uniti, 94596
- Kaiser Permanente Central Diablo (Wlanut Creek/ Martinez)
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- men and women
- over the age of 18
- currently enrolled in outpatient treatment program for drug and/or alcohol use and have received minimally 30 days of continuous treatment for drug and/alcohol in any outpatient treatment program(s) for drug and/or alcohol use for at least one month
- have regularly smoked cigarettes for at least one year in their lifetime
- have smoked within the past 5 years
Exclusion Criteria:
- clients with a life-threatening disease
- currently at imminent risk of committing suicide, or currently pregnant
- currently in treatment for nicotine dependence elsewhere
- cannot be reached by telephone (unable to provide a phone number where the participant can be reached directly
- non-English speakers.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Altro: 1
Assessment only + referral list to State quitline and smoking cessation education classes at Kaiser
|
Referral list to smoking cessation classes at Kaiser and the California Smokers Helpline
|
Sperimentale: 2
Participants will receive self-help information handouts, expert system intervention that includes a stage-based manual and individualized written feedback reports plus in-person brief stage-appropriate counseling at baseline and 3-month assessment.
Current smokers who indicate desire to quit smoking or former smokers who indicate high cravings for cigarettes will be offered nicotine replacement medications.
Participants will receive three telephone counseling sessions delivered between baseline and 3 month at weeks 2, 4 and 8. As-needed telephone check-calls will be provided to participants on and 2 days after quit date, or to participants who have quit smoking and anticipate high risk situations.
|
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
---|---|
CO verified self-report 7-day smoking abstinence prior to assessment
Lasso di tempo: 6 months
|
6 months
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Janice Tsoh, PhD, University of California, San Francisco
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- P50DA009253-14-DevStudy2
- H10315-28247-03
- P50DA009253-14 (Sovvenzione/contratto NIH degli Stati Uniti)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Control
-
University of California, Los AngelesCompletatoDiabete di tipo 2Stati Uniti
-
Johns Hopkins UniversityCompletato
-
University of Southern CaliforniaPendulum TherapeuticsRitiratoDiabete di tipo 2 | Sintomi gastrointestinaliStati Uniti
-
Rethink Medical SLReclutamentoQualità della vita | Complicanza correlata al catetere | Infezione del tratto urinario associata a catetereSpagna
-
Rethink Medical SLRitiratoRitenzione urinaria | Complicazioni del catetere | Infezione del tratto urinario associata a catetereSpagna
-
Nephera Ltd.SconosciutoInsufficienza renale | Insufficienza cardiaca, congestizia | Scompenso cardiacoIsraele
-
Icahn School of Medicine at Mount SinaiReclutamento
-
Ulrike WillutzkiUniversity of BernReclutamentoDisordini mentali | Intervento onlineGermania
-
Devicare S.L.Clever Instruments S.L.; Fundacio PuigvertSconosciuto
-
Gonzalez-Heydrich, Joseph, M.D.Boston Children's Hospital; Harvard UniversityCompletatoLa rabbia | AggressioneStati Uniti